Announcements

Removal of Component(s) – MYOV

February 27, 2023

LifeSci Biotechnology Products Index

Effective at the market close on Tuesday, February 28, 2023, MYOV will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights.

On October 23, 2022, Myovant Sciences announced that it would be acquired by Sumitomo Pharma for $27.00/share in cash.